Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00343681 | A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine | PHASE2 | COMPLETED | 120 | — | — | Jul 1, 2006 | Aug 1, 2007 | Jan 17, 2014 | 2 | Switzerland, United Kingdom |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Inactivated influenza vaccine (split virion) | BIOLOGICAL | 0.5 mL, Intramuscular |
Inclusion Criteria: * Aged at least 18 years on the day of inclusion * Informed consent form signed * Able to attend all scheduled visits and to comply with all trial procedures * For a woman, inability to bear a child or negative urine pregnancy test at Visit 1 * For a woman of child-bearing poten...